Tech Company Financing Transactions

Accent Therapeutics Funding Round

EcoR1 Capital Management, AbbVie Biotech Ventures and Atlas Venture invested in a $63 million Series B funding round for Accent Therapeutics. The round was announced on 4/24/2020.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

65 Hayden Ave.
Lexington, MA 02421
USA

Phone

(339) 970-7400

Website

www.accenttx.com

Email Address

[email protected]

Overview

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Shakti Narayan

        

Chief Financial Officer

Nicole Heifner

        

President

Robert Copeland

        

Vice President

Ann Boriack-Sjodin

        

Vice President

Kenneth Duncan

        

Vice President

Scott Ribich

        

VP - Bus. Development

David Brower

        

Browse more venture capital transactions:

Prev: 4/24/2020: CMLaser Technologies venture capital transaction
Next: 4/24/2020: Equispheres venture capital transaction

Share this article

About Database of VC Transactions

We record funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary